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Abstract
Objectives—To evaluate an external quality assessment (EQA) program for human 
immunodeficiency virus (HIV) rapid diagnostics testing by the Haitian National Public Health 
Laboratory (French acronym: LNSP). Acceptable performance was defined as any proficiency 
testing (PT) score more than 80%.
Methods—The PT database was reviewed and analyzed to assess the testing performance of the 
participating laboratories and the impact of the program over time. A total of 242 laboratories 
participated in the EQA program from 2006 through 2011; participation increased from 70 
laboratories in 2006 to 159 in 2011.
Results—In 2006, 49 (70%) laboratories had a PT score of 80% or above; by 2011, 145 (97.5%) 
laboratories were proficient (P < .05).
Conclusions—The EQA program for HIV testing ensures quality of testing and allowed the 
LNSP to document improvements in the quality of HIV rapid testing over time.
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Access to human immunodeficiency virus (HIV) diagnosis and treatment has expanded 
rapidly in Haiti. National efforts to scale up care and treatment services for individuals with 
HIV depend on efficient laboratory services, including HIV testing, which is the main entry 
point to access to care and treatment. Despite increased access to HIV counseling and testing 
in developed countries, most people living with HIV in low- and middle-income countries 
are unaware of their serostatus.1 While available rapid diagnostic tests (RDTs) for HIV have 
high sensitivity and specificity when performed correctly, incorrect use can result in 
incorrect results, with serious consequences. It is estimated that 430,000 people out of 86 
million who benefited from HIV testing through the US President's Emergency Plan for 
AIDS Relief will have received erroneous results, assuming an error rate as low as 0.5%.2 
Errors can occur at any stage of the testing process: in the preanalytical stage (storage 
outside the recommended temperatures, collecting specimens incorrectly, and expired test 
kits), in the analytical stage (deviation from testing procedures, misinterpretation of results, 
and poor test performance), and the postanalytical stage (documentation errors).3,4
External quality assessment (EQA) is critical to assess the quality of laboratory performance 
and to ensure accuracy and reliability of laboratory results.5 The World Health Organization 
recommends a three-phase approach to implement HIV RDTs that includes (1) evaluating 
HIV rapid test kits, (2) piloting of the selected algorithm, and (3) monitoring the quality of 
testing through an EQA program. Based on these guidelines, the implementation of a 
national HIV testing algorithm should be accompanied by ongoing EQA to monitor 
performance.6 Key components of HIV EQA are (1) retesting, (2) onsite technical 
assistance, and (3) a proficiency testing (PT) program that evaluates technical competence.7 
A PT program is a periodic check on testing processes and laboratory performance8 where 
unknown samples are sent by an external provider for testing to a set of laboratories, and 
subsequently the results of all laboratories are analyzed, compared with those of the 
reference laboratory and reported back.
In Haiti, most HIV testing is performed by trained technicians in a laboratory setting using 
RDTs. The first step in expanding HIV RDTs was to implement and validate a national 
algorithm. In 2006, Haiti adopted a testing algorithm based on two sequential rapid tests.9 
Three tests were approved: two rapid immunochromatographic assays—Abbott Determine 
HIV1/2 (Abbott Laboratories, Abbott Park, IL) or OraQuick ADVANCE Rapid HIV-1/2 
(OraSure Technologies, Bethlehem, PA)—for use as a screening test and one rapid latex 
agglutination assay, Trinity Biotech Plc Capillus HIV-1/HIV-2 (Trinity Biotech Plc, 
Wicklow, Ireland), for use as a confirmatory test. In 2011, the national algorithm was 
reviewed, and Capillus was replaced by a rapid immunochromatographic assay, HIV (1+2) 
Antibody (Colloidal Gold) (KHB; Shanghai Kehua Bio-engineering, Shanghai, China).
Following validation by the National Public Health Laboratory (French acronym: LNSP), 
the HIV RDTs were made available throughout the 10 departments (states/provinces) of the 
country. In accordance with its essential role in ensuring the quality of HIV tests nationally, 
the LNSP developed guidelines for test performance, provided rigorous training to guarantee 
high quality and standardized testing, and established an EQA program for laboratories 
within the network.
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We reviewed the implementation of the EQA program and analyzed data from 2006 through 
2011 to evaluate the quality of HIV testing and changes in PT performance over time.
Materials and Methods
Implementation of the PT Program
In 2006, the LNSP conducted an initial training on the implementation of the national 
algorithm for HIV testing, the importance of the HIV RDT EQA, and the procedures for 
testing the PT panels. Laboratories from all sectors (public, private, and mixed public/
private) in the country were invited to participate in the training and EQA program. 
Following the initial training, PT panels (described in detail below) were sent out free of 
charge to the laboratories using cold chain transport. Laboratories were instructed to 
complete the PT testing within 4 weeks of receiving the PT panels. Each participating 
laboratory recorded the results of proficiency testing on paper forms along with information 
about the date of testing and the tests performed (eg, test kits used and number of tests 
done). These PT results were collected by LNSP staff and recorded in a central database at 
the LNSP. Panels were distributed once a year in 2006, 2007, and 2008. In 2009, the 
distribution frequency was increased to twice a year, but because of logistical constraints, 
panels were distributed once per year in 2010 and 2011. Laboratories with PT performance 
less than 80% were visited by senior technicians and assessed (eg, for availability of test kits 
and proper test performance) and received follow-up training on RDT use, the importance of 
following the national algorithm for HIV RDTs, and Good Laboratory Practices.
PT Panel Description—In 2006 and 2007, panels of six (three positive and three 
negative) HIV seroconversion serum samples were purchased (seroconversion panels; 
ZeptoMetrix, Buffalo, NY) and distributed nationally by the LNSP. These panels were 
nonreactive for hepatitis B surface antigen, human T-lymphotropic viruses 1 and 2, and 
syphilis. In 2008, to reduce transport costs and in line with evolving recommendations, the 
liquid PT panels were substituted by panels of dried tube specimens (DTS), prepared at the 
LNSP according to the method described by Parekh et al.10 Briefly, discarded and 
deidentified units of blood collected from the national blood transfusion center were 
characterized using an enzyme-linked immunosorbent assay, and panels of six DTS (three 
HIV positive and three HIV negative) were prepared by transferring 20 μL of plasma, 
premixed with 0.1% (v/v) green dye, into 2-mL Sarstedt tubes (Sarstedt Group, Nümbrecht, 
Germany). The tubes were allowed to dry overnight at room temperature in a biosafety 
cabinet and stored at 4°C until rehydrated prior to testing. Ten percent of the panels were 
retested at the LNSP for quality control using the HIV rapid test algorithm. The PT panels 
were subsequently packaged and shipped to the participating laboratories along with 
required buffer and instructions for reconstitution.
Analysis of PT Data—Participation rate and PT scores were compared between 
categories of laboratories and departments during the 6-year period using analysis of 
variance. Acceptable performance was defined as any PT score of 80% or above. All data 
were analyzed using SPSS version 13.0 (SPSS, Chicago, IL). We also reviewed forms to 
identify possible reasons for nonconcordant results and evaluated the impact of training and 
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other corrective actions by assessing follow-up PT scores for laboratories that were not 
proficient during initial testing.
Results
Participating Laboratories
From 2006 through 2011, 263 unique laboratories enrolled in the program and received PT 
panels Table 1. Overall, 242 laboratories reported results at least once; response rates across 
laboratories ranged from 86% to 98% (Table 1). Most laboratories participated in the EQA 
program more than once in the six-year period; 27 (11%) participated only once. The 242 
laboratories participating in the national EQA from 2006 through 2011 included laboratories 
from all 10 geographic departments Figure 1A. The greatest number of participating 
laboratories was from the Ouest department, with 99 participating laboratories (41% of the 
total). Of the 242 participating laboratories, 125 (52%) were private institutions, 69 (28%) 
were public laboratories, and 48 (20%) were mixed Figure 1B (mixed facilities are those 
with private management and personnel employed by the ministry of health) (Table 1).
PT Performance
Over all PT rounds between 2006 and 2011, the results of proficiency testing were 93% 
concordant with reference results. Laboratories from the Nord-Ouest department had the 
lowest average PT score of 87%, and laboratories from the department/province/state of 
Nippes scored an average PT score of 95% concordance with reference results, but the 
differences in scores by department were not significant (P > .05) Figure 2. Increasing PT 
scores were observed from 2006 through 2011, with the lowest score (87.7%) observed in 
2008 and the highest score (97.8%) in 2011 Figure 3. In 2006 and 2007, 49 (70%) and 73 
(60%) participating laboratories scored 100% in PT; by 2011, 145 laboratories (91.2%) 
scored 100% (P < .05). In 2006, 49 (70%) laboratories had a PT score of 80% or above; by 
2011, 145 (97.5%) laboratories were proficient (P < .05). Despite the overall trend of 
improving scores, average PT scores declined in 2008 and 2010 compared with previous 
years. There were no significant differences in PT scores between the three categories of 
laboratories (private, public, and mixed; P > .05). Key reasons for discordant results were 
mainly inaccuracy in interpreting Capillus results and use of a single test to diagnose HIV. 
Laboratories participating in the EQA program after failing the first PT program in 2006 
significantly improved their PT scores (P < .05) following training and onsite technical 
assistance by senior laboratory technicians from the LNSP; these laboratories have 
maintained an average PT score of at least 91% in subsequent participations Figure 4.
Discussion
During the recent rapid expansion of HIV diagnostic and treatment programs in Haiti, it has 
been imperative to optimize the quality of testing using HIV RDTs. We report the successful 
implementation of an EQA program for HIV testing in Haiti and overall high rates of 
proficiency. While PT proficiency is only one measure of testing quality, our results provide 
some assurance that laboratories in Haiti are providing accurate results using the rapid 
diagnostics platform.
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We observed generally increasing participation in the EQA program from 2006 through 
2011, which suggests growing interest and positive response to the national EQA program 
from HIV testing laboratories. Private laboratories participated extensively in the national 
HIV RDT EQA program. Since no national laboratory certification policy has been 
implemented to date, participation in the national EQA program may be considered a means 
for private laboratories to ensure quality of their testing and increase client confidence in 
their institutions. The greatest number of participating laboratories was in the Ouest 
department, which was expected since this department has the largest population, and more 
than 50% of all laboratories nationally are located in this department.
The decline in PT scores in 2008 and 2010 was likely related to staff turnover following the 
two major natural disasters (2008 Atlantic hurricane season and 2010 earthquake). 
Proficiency testing performance significantly improved following training and technical 
assistance, suggesting that these interventions were effective.
Our results reinforce the previous observations made by others that experience and training 
significantly affect the accuracy of rapid HIV test results.11–14 We believe the 
implementation of the EQA program for HIV testing had additional benefits—for example, 
helping to strengthen the relationships within the laboratory network as well as improving 
communication between the networks and the national reference laboratory, as it has been 
observed elsewhere.15
As Haiti scales up the number of hospitals or clinics providing HIV antiretroviral therapy 
with laboratory capacity, quality assurance of testing will remain a challenge. While 
increasing efforts have been made to assess and evaluate the quality of HIV RDTs 
nationwide, poor infrastructure and national policies for a laboratory system still need to be 
addressed. In addition, there is a need to expand EQA to other laboratory programs and to 
standardize the panels' distribution frequency. A national laboratory network plan was 
developed in 2010, categorizing laboratories into a tiered system network with the LNSP as 
the national reference laboratory and specifying a menu of tests for each level of laboratory. 
Next steps include implementation of standard laboratory policies and development of a 
laboratory certification system. Decentralization of laboratory services is also an important 
priority. As indicated by this evaluation, almost half of the laboratories enrolled in the 
national HIV testing EQA program are in the Ouest department. Strengthening laboratory 
infrastructure and testing capacities at the departmental level is key to increasing access to 
quality of laboratory services in Haiti. With the ultimate goal to achieve international 
accreditation, four laboratories in the country, including the LNSP, are enrolled in the 
Strengthening Laboratory Management System Towards Accreditation program, which is a 
stepwise process to improve quality management based on the model by the World Health 
Organization's Regional Office for Africa.16 During this process, continuous reinforcement 
of training and updating of national guidelines in line with rapid technological advancement 
will also be essential.17 The path is long toward increasing access to high-quality laboratory 
services in Haiti, but a lot of progress has been made since the inauguration of the LNSP in 
2006. The national EQA program for HIV RDTs is a model of success that needs to be 
replicated to other pathogen diagnoses to extend the laboratory network and ensure the 
quality of results and patient satisfaction.
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Upon completion of this activity you will be able to:
• describe the importance of ensuring quality for laboratory testing.
• outline the three-stage process recommended by the World Health Organization 
and the three key components necessary to implement an external quality 
assurance program for human immunodeficiency virus testing.
• discuss the potential impact of training and technical assistance on proficiency 
testing performance.
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Number of laboratories participating in Haiti's national human immunodeficiency virus 
external quality assessment program by (A) department and (B) institution type.
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Average proficiency testing (PT) score for laboratories participating in Haiti's national 
human immunodeficiency virus external quality assessment program by department and PT 
round. P > .05, analysis of variance.
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Performance of all participating laboratories on the national human immunodeficiency virus 
external quality assessment program from 2006 through 2011. P < .05, analysis of variance. 
PT, proficiency testing.
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Proficiency testing (PT) scores over time for laboratories scoring less than 80% in 2006. P 
< .001, Student t test.
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Table 1
Participation in Haiti's National Human Immunodeficiency Virus External Quality Assessment Program From 
2006 Through 2011
Year No. of Laboratories Enrolled No. of Laboratories Responding Response Rate, %
2006 76 70 92
2007 128 122 95
2008 76 73 96
2009 (Distribution 1) 179 175 98
2009 (Distribution 2) 209 189 90
2010 146 129 88
2011 185 159 86
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